Postoperative Pain and Substance P Levels After Bioceramic vs Calcium Hydroxide Intracanal Medicaments in Symptomatic Apical Periodontitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorFuture University in Egypt

About this trial

Clinical Evaluation of the Postoperative Pain and Substance P levels Following the use of Bioceramic verses Calcium Hydroxide Intracanal Medicaments in Permanent Mandibular molars with Symptomatic Apical Periodontitis

Eligibility criteria

Qualifiers

- Patients aged 18-45 years with no sex predilection

Medically free Patients with no systemic conditions that can affect post operative pain response.

Patients should not be taking any pain medications 24 hours before intervention

Positive patients' acceptance for participating in the study

Disqualifiers

- Medically compromised patients

Patients who have received antibiotic therapy within the last 2 weeks.

Pregnant or lactating women.

Patients with known allergy to any of the irrigants used.

Trial design

Treatments tested in this trial

  • Calcium Hydroxide (Ca(OH)2)
  • Bioceramic Intracanal Medicament

Treatment groups

28 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators